EP2982366
Lyfjaskammtaform fyrir lyfjagjöf með Bcl-2 fjölskylduhemlum um munn
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
8.6.2010EP published:
13.9.2017EP application number:
15184904.9
EP translation filed:
4.12.2017Grant published:
15.12.2017EPO information:
European Patent Register
Max expiry date:
7.6.2030Expiry date:
7.6.2025
Title:
PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL-2 FAMILY INHIBITOR
Timeline
Today
8.6.2010EP application
13.9.2017EP Publication
4.12.2017Translation submitted
15.12.2017Registration published
7.6.2025Expires
Owner
Name:
AbbVie Deutschland GmbH & Co. KGAddress:
Mainzer Strasse 81, 65189, Wiesbaden, DE
Inventor
Name:
PACKHAEUSER, ClaudiaAddress:
Mannheim, DE
Name:
STEIGER, NorbertAddress:
Lingenfeld, DE
Name:
LIEPOLD, BerndAddress:
Dossenheim, DE
Name:
KOSTELAC, DrazenAddress:
Mannheim, DE
Name:
KNOBLOCH, MartinAddress:
Neuhofen, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
185130 PDate:
8.6.2009Country:
US
Classification
Categories:
A61K 9/00, A61K 31/5377, A61K 9/14, A61K 31/635, A61K 47/22, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 9.5.2018
Expires: 7.6.2019
Payer: Örn Þór, slf.
Number: 10
Paid: 14.5.2019
Expires: 7.6.2020
Payer: Örn Þór, slf.
Number: 11
Paid: 15.5.2020
Expires: 7.6.2021
Payer: Örn Þór slf.
Number: 12
Paid: 12.5.2021
Expires: 7.6.2022
Payer: Örn Þór slf.
Number: 13
Paid: 18.5.2022
Expires: 7.6.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 24.5.2023
Expires: 7.6.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 13.5.2024
Expires: 7.6.2025
Payer: Árnason Faktor ehf.